Esprit Funds 2nd Phase of Work

BRUSSELS—Some 500 companies will benefit from the five-year, $2 billion budget set by research miniisters for the second phase of the European Economic Community’s Esprit program of information technology research. The agreement secures the immediate future for 3,000 researchers and 200 projects whose Esprit 1 funding had virtually expired and who had been pawns for the past year in the British government’s opposition to the EEC’s intended funding for collaborative re

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BRUSSELS—Some 500 companies will benefit from the five-year, $2 billion budget set by research miniisters for the second phase of the European Economic Community’s Esprit program of information technology research.

The agreement secures the immediate future for 3,000 researchers and 200 projects whose Esprit 1 funding had virtually expired and who had been pawns for the past year in the British government’s opposition to the EEC’s intended funding for collaborative research. Total spending for the second phase will be $4 billion (companies involved in the pre-competitive program have promised to match government contributions), and is meant to develop common software standards for manufacturing and office automation, information processing, advanced components and microelectronics.

Esprit is the largest component of the EEC’s overall $6.5 billion research program. Research ministers also agreed to nearly double the current five-year, $80 million budget for Brite, a project to revitalize traditional industries with modern technology. They ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery